Alleen buys REGN 324.31: Regeneron Pharmaceuticals Inc. (REGN) Is Surging On Phase 3 Study Results
(RTTNews.com) - Regeneron Pharmaceuticals Inc. ( REGN) and Sanofi ( SNY) announced Wednesday morning that nine new Phase 3 ODYSSEY trials of alirocumab, in patients with hypercholesterolemia, met their primary efficacy endpoint of a greater percent ... ...
24 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home